# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001829126-25-007289
Filing Date
2025-09-10
Accepted
2025-09-10 16:05:26
Documents
22
Period of Report
2025-10-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | novabay_pre14a.htm iXBRL | PRE 14A | 1236557
2 | GRAPHIC | img_001.jpg | GRAPHIC | 8608
3 | GRAPHIC | img_002.jpg | GRAPHIC | 85085
4 | GRAPHIC | img_003.jpg | GRAPHIC | 36823
5 | GRAPHIC | img_004.jpg | GRAPHIC | 37406
6 | GRAPHIC | proxy_001.jpg | GRAPHIC | 651073
7 | GRAPHIC | proxy_002.jpg | GRAPHIC | 388593
| Complete submission text file | 0001829126-25-007289.txt |  | 4846922

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | cik0001389545-20241231.xsd | EX-101.SCH | 5705
9 | XBRL DEFINITION FILE | cik0001389545-20241231_def.xml | EX-101.DEF | 9525
10 | XBRL LABEL FILE | cik0001389545-20241231_lab.xml | EX-101.LAB | 58737
11 | XBRL PRESENTATION FILE | cik0001389545-20241231_pre.xml | EX-101.PRE | 41926
24 | EXTRACTED XBRL INSTANCE DOCUMENT | novabay_pre14a_htm.xml | XML | 108036

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33678 | Film No.: 251305923
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)